Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
Mohamed F Doheim, Assistant Professor in Neurology (Clinical Research), NIH StrokeNet Fellow at the University of Pittsburgh School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neurology, adding:
”Excited to share my second publication in Neurology in a single day; this time on extended-window IV thrombolysis (IVT) for acute ischemic stroke (4.5–24 hours).
Across 18 RCTs and 5,168 patients, extended-window IVT improved excellent and good functional outcomes and reduced disability on the full mRS spectrum, with the expected increase in sICH but no excess mortality.
The central insight is why trial results have looked so heterogeneous.
Using multivariable meta-regression, we found that the main driver of between-study heterogeneity is whether patients also have access to endovascular thrombectomy (EVT).
Once EVT context is accounted for, much of the apparent variability in IVT effect becomes explainable.
Clinically, this means extended-window IVT may offer its greatest benefit in settings where thrombectomy is unavailable or delayed, especially for more severe strokes, positioning late IVT as a critical global reperfusion strategy rather than a niche protocol.
Proud to help clarify how IVT and EVT interact across trials and health systems, and to contribute evidence that can inform both guideline discussions and stroke systems of care worldwide.”
Title: Exploring Between-Study Heterogeneity in Extended-Window IV Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of 18 Randomized Controlled Trials
Authors: Mohamed F. Doheim, Abdullah M. Al-Qudah, Romil Singh, Nirav R. Bhatt, Marcelo Rocha, Lawrence R. Wechsler, Gaoting Ma, Gisele Sampaio Silva, Sheila Co Martins, Chunrong Tao, Junwei Hao, Yamei Tang, Wei Hu, Lee H. Schwamm, Thanh N. Nguyen, Raul G. Nogueira

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments